SOX2 and neoplasm: Doxorubicin alone was sufficient to reduce primary tumor growth but prior exposure to doxorubicin was required for T12 to inhibit metastases formation (Figure 9H) and to reduce Sox2 expression (Supplementary Figure 9F).